These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 35507150

  • 21. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
    Jayaraman VK, Thomas M.
    BMJ Case Rep; 2016 Feb 17; 2016():. PubMed ID: 26887886
    [Abstract] [Full Text] [Related]

  • 22. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K, Warner E, Bollinger C, Wright D, Fitch RM.
    BMC Nephrol; 2020 Jun 15; 21(1):226. PubMed ID: 32539845
    [Abstract] [Full Text] [Related]

  • 23. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
    Miura K, Kaneko N, Hashimoto T, Ishizuka K, Shirai Y, Hisano M, Chikamoto H, Akioka Y, Kanda S, Harita Y, Yamamoto T, Hattori M.
    Pediatr Nephrol; 2023 Feb 15; 38(2):417-429. PubMed ID: 35655039
    [Abstract] [Full Text] [Related]

  • 24. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, Koziell A, Zaritsky JJ.
    Pediatr Nephrol; 2019 Nov 15; 34(11):2343-2350. PubMed ID: 31250206
    [Abstract] [Full Text] [Related]

  • 25. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K, Kurihara H, Horita S, Chikamoto H, Hattori M, Harita Y, Tsurumi H, Kajiho Y, Sawada Y, Sasaki S, Igarashi T, Kunishima S, Sekine T.
    Nephrol Dial Transplant; 2013 Dec 15; 28(12):2993-3003. PubMed ID: 24042022
    [Abstract] [Full Text] [Related]

  • 26. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B, Knüppel T, Waldherr R, Schaefer F, Weber S, Tönshoff B.
    Pediatr Nephrol; 2006 Oct 15; 21(10):1476-9. PubMed ID: 16721582
    [Abstract] [Full Text] [Related]

  • 27. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J, Pippin JW, Krofft RD, Naito S, Liu ZH, Shankland SJ.
    Am J Physiol Renal Physiol; 2013 Jun 01; 304(11):F1375-89. PubMed ID: 23486009
    [Abstract] [Full Text] [Related]

  • 28. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S, Vlachopanos G, Georgalis A, Liapis G, Skalioti C, Zavos G, Boletis JN.
    Ren Fail; 2015 Jun 01; 37(5):777-83. PubMed ID: 25715638
    [Abstract] [Full Text] [Related]

  • 29. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A, Piecha G, Więcek A.
    Transplant Proc; 2016 Nov 01; 48(9):3092-3094. PubMed ID: 27932154
    [Abstract] [Full Text] [Related]

  • 30. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.
    Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, Carson T, Florman S, Vehaskari MV.
    Pediatr Transplant; 2014 Feb 01; 18(1):29-34. PubMed ID: 24266922
    [Abstract] [Full Text] [Related]

  • 31. Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience.
    Alhasan KA, Alherbish A, Osman A, Kari JA, Almojalli H.
    Transplant Proc; 2019 Mar 01; 51(2):517-521. PubMed ID: 30879580
    [Abstract] [Full Text] [Related]

  • 32. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.
    Dado D, Parikh S, Ayoub I, Rovin B, Nadasdy T, Hebert L.
    Clin Nephrol; 2018 May 01; 89(5):376-380. PubMed ID: 29249233
    [Abstract] [Full Text] [Related]

  • 33. Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis.
    Hamroun A, Gibier JB, Maanaoui M, Lionet A, Gnemmi V, Bouyé S, Fantoni JC, Averland B, Antoine C, Lenain R, Hazzan M, Provôt F.
    Am J Kidney Dis; 2021 Dec 01; 78(6):897-901. PubMed ID: 34118304
    [Abstract] [Full Text] [Related]

  • 34. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.
    Am J Nephrol; 2017 Dec 01; 46(2):108-113. PubMed ID: 28700988
    [Abstract] [Full Text] [Related]

  • 35. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, Sanna-Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM.
    Am J Kidney Dis; 2003 Jun 01; 41(6):1314-21. PubMed ID: 12776285
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M, Aala A, Alasfar S, Alachkar N.
    BMC Nephrol; 2020 Jul 02; 21(1):253. PubMed ID: 32615995
    [Abstract] [Full Text] [Related]

  • 37. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N, Chung CF, Benderoff E, Babayeva S, Bitzan M, Goodyer P, Kitzler T, Matar D, Cybulsky AV, Alachkar N, Torban E.
    Am J Physiol Renal Physiol; 2016 May 15; 310(10):F1148-56. PubMed ID: 26719363
    [Abstract] [Full Text] [Related]

  • 38. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
    Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW.
    Sci Transl Med; 2011 Jun 01; 3(85):85ra46. PubMed ID: 21632984
    [Abstract] [Full Text] [Related]

  • 39. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
    Alachkar N, Wei C, Arend LJ, Jackson AM, Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J, Estrella MM.
    Transplantation; 2013 Oct 15; 96(7):649-56. PubMed ID: 23842190
    [Abstract] [Full Text] [Related]

  • 40. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Torres VE, Velosa JA, Holley KE, Frohnert PP, Zincke H, Sterioff S.
    Mayo Clin Proc; 1984 Mar 15; 59(3):146-52. PubMed ID: 6369011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.